Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 72Esophageal Squamous Cell Carcinoma 41Carcinoma, Non-Small-Cell Lung 32Stomach Neoplasms 31Colorectal Neoplasms 29Ovarian Neoplasms 25Pancreatic Neoplasms 21Adenocarcinoma Of Esophagus 16Breast Neoplasms 15Lung Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Sarcoma 10Neoplasm Metastasis 10Melanoma 10Liver Neoplasms 10Endometrial Neoplasms 10Colonic Neoplasms 9Neoplasms 8Hepatoblastoma 8Head and Neck Neoplasms 8Cholangiocarcinoma 8Carcinoma, Hepatocellular 8Uterine Cervical Neoplasms 7Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Carcinoma, Renal Cell 7Anus Neoplasms 7Rectal Neoplasms 6Carcinoma, Squamous Cell 6Testicular Neoplasms 5

Interventions

Nivolumab 2pembrolizumab 1folfirinox 1durvalumab 1Trastuzumab 1Single Person 1Paclitaxel 1Irinotecan 1IFL protocol 1Folfox protocol 1Docetaxel 1Carboplatin 1((S)-2-(5-(1,2-dihydro-3-methyl-1-oxobenzo(f)-quinazoline-9-yl)methyl)amino-1-oxo-2-isoindolynyl)-glutaric acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastroesophageal Adenocarcinoma × Carboplatin × Gastrointestinal × Clear all
NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡